CVS HEALTH Corp CVS
Retail-Drug Stores and Proprietary Stores · NYSE
Revenue
$177.53B
+0.0% YoY
Net income
$8.34B
+93.6% YoY
Total assets
$253.22B
+1.4% YoY
EPS
6.47
+98.5% YoY
Advertisement
Income Statement
| Period | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Revenues | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Operating Income (Loss) | $5.75B | $3.37B | $13.74B | $6.15B | $5.32B | $2.27B | $7.95B | $10.37B |
| Interest Expense | — | — | — | — | — | — | — | — |
| Net Income (Loss) | $2.80B | $1.78B | $8.34B | $2.97B | $2.88B | $1.11B | $4.31B | $6.30B |
| EPS (Diluted) | 2.21 | 1.41 | 6.47 | 2.35 | 2.28 | 0.88 | 3.26 | 4.88 |
Balance Sheet
| Period | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $253.54B | $253.54B | $253.22B | $253.22B | $253.22B | $253.22B | $249.73B | $249.73B |
| Current Assets | $74.71B | $74.71B | $68.64B | $68.64B | $68.64B | $68.64B | $67.86B | $67.86B |
| Cash & Equivalents | $8.45B | $8.45B | $8.20B | $8.59B | $8.59B | $8.59B | $12.95B | $8.20B |
| Accounts Receivable | $39.78B | $39.78B | $36.47B | $36.47B | $36.47B | $36.47B | $35.23B | $35.23B |
| Inventory | $19.25B | $19.25B | $18.11B | $18.11B | $18.11B | $18.11B | $18.02B | $18.02B |
| PP&E (Net) | — | — | — | — | — | — | — | — |
| Goodwill | $85.48B | $85.48B | $91.27B | $91.27B | $91.27B | $91.27B | $78.15B | $91.27B |
| Total Liabilities | $178.16B | $178.16B | $177.49B | $177.49B | $177.49B | $177.49B | $173.09B | $173.09B |
| Current Liabilities | $88.69B | $88.69B | $84.61B | $84.61B | $84.61B | $84.61B | $79.19B | $79.19B |
| Accounts Payable | — | — | — | — | — | — | — | — |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Stockholders Equity | $75.21B | $75.21B | $75.56B | $75.56B | $75.56B | $75.56B | $76.46B | $76.46B |
Cash Flow Statement
| Period | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.45B | $4.56B | $13.43B | $7.25B | $7.99B | $4.90B | $16.18B | $16.06B |
| Investing Cash Flow | $-1.79B | $-762.00M | $-20.89B | $-7.07B | $-3.72B | $-2.09B | $-5.05B | $-19.65B |
| Financing Cash Flow | $-1.53B | $-2.33B | $2.68B | $-1.57B | $22.00M | $-1.23B | $-10.52B | $3.65B |
| Stock Repurchases | — | — | $2.01B | $3.02B | $3.02B | $3.03B | $3.50B | $2.01B |
Learn more
How to Find Any SEC Filing in Two MinutesCash-Flow Quality: Profit Is an Opinion, Cash Is a FactValuation Basics: P/E, P/S and What They Actually Tell YouDividends: How Companies Pay Shareholders and How to Read ThemHow to Read a 10-K Annual Report (Without Falling Asleep)Understanding Earnings Per Share (EPS)How to Read a Cash Flow StatementHow to Read a Balance SheetHow to Read an Income Statement
Data is sourced from the U.S. SEC EDGAR public database. This site does not provide investment advice.